Effect of alkylphospholipids on Candida albicans biofilm formation and maturation

Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in Italy

(2011) Matteo Bassetti et al.   PLoS One

Design and synthesis of new adamantyl-substituted antileishmanial ether phospholipids

(2010) Ioannis Papanastasiou et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases

(2010) L.A. Braga-Silva et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Epidemiology of Opportunistic Fungal Infections in Latin America

(2010) Marcio Nucci et al.   CLINICAL INFECTIOUS DISEASES

Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids

(2010) José M Jiménez-López et al.   Lipids in Health and Disease

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Thymol inhibits Candida albicans biofilm formation and mature biofilm

(2008) Pier Carlo Braga et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Design and Synthesis of Potent Antileishmanial Cycloalkylidene-Substituted Ether Phospholipid Derivatives

(2008) Theodora Calogeropoulou et al.   JOURNAL OF MEDICINAL CHEMISTRY